Rheumatoid arthritis, lupus, and, to a degree, fibromyalgia are all arthritis-related conditions triggered by defective immune system (collectively called autoimmune conditions). When one’s immune system, responsible for fighting viruses, bacteria and germs, cannot tell the difference between these foreign invaders and one’s healthy cells, it creates auto antibodies that attack healthy tissue. These autoantibodies cause inflammation pain and damage in various parts of the body.

Although the direct causes of specific autoimmune conditions are not yet fully understood, doctors have found that people with rheumatoid arthritis have lower levels of common antioxidants in their blood in the years before the disorder is diagnosed. Also, arthritis (but also osteoporosis, cardiovascular disorders, and others) has been directly linked to a lack of minerals.

And FulvicForce fulvic acid certainly possess properties, which make it a good candidate for helping in various autoimmune conditions:

(1) Fulvic acid contains lots of phytochemicals of ancient plant origin, which have the most valuable nutrients, provide anti-oxidant action and have anti-viral, anti-bacterial, anti-microbial and anti-inflammatory properties.

(2) Fulvic acid effectively helps to dissolve vegetal silica for collagen, it thus repairs, strengthens and protects connective tissue: ligaments, tendons and joints.

(3) Fulvic acid is known to be one of the strongest natural anti-oxidants and free-radical scavengers. It is proven that fulvic acid can effectively neutralise and even repair some free radicals, which limits free radical damage.

(4) Fulvic acid provides the most effective cellular oxygenation in Nature. Its molecule, by weight, is made of 45% oxygen, 45% carbon and the balance of 10% is made of hydrogen, nitrogen and sulphur. This highly bio-active and bio-available oxygen goes straight inside body cells providing sustained energy, cleansing and protection.

(5) Fulvic acid chelates into its molecular structure more than 70 minerals and trace elements, which are then effectively transported to the body cells. Many of these essential elements are conductive, which makes fulvic acid a natural electrolyte

The baleotherapeutic use of peat, rich in humic substances (humic and fulvic acids), is practiced for centuries. Traditional indication for such therapies are rheumatic and gynaecological diseases. Many clinics in Europe offer peat therapies for muscoskoskeletal diseases: degenerative and deforming arthroses, gout, osteoporosis, muscular rheumatism, rheumatoid arthritis, rehabilitation after operations and accident, and skin diseases: chronic eczema neurodermatitis and psoriasis.

Not only do the humic substances relieve swelling from joint inflammation, they been shown to bond to the collagen fibers to aid in repair of damaged tendons and bone. Tendon strength has been shown to increase by as much as 75%.

Fulvic acid and vegetal silica appear to have the unique ability to interact positively with degenerative calcium deposits and unhealthy bone structures in the body. Arthritis sufferers taking a combination of fulvic and humic acids and vegetal silica have noticed an immediate and marked increase in discomfort, and this has continued for 1 to 2 weeks or sometimes longer after beginning of use. This discomfort is believed to be due to the breakdown of calcium deposits in the joints and its ongoing and subsequent mobilization, dissolution, and removal. It is further believed that these calcium deposits react with the fulvic and humic acids minerals, and silica and transmutate in to more suitable forms that become beneficial to the body.

FulvicForce is South Africa’s one and only fulvic acid product extracted from coal according to a patented process. FulvicForce product is literally an organic extract from plants, which lived hundreds of millions years ago, thus carrying their mineral, nutritional and remedial value, concentrated through a slow natural refinement process of transforming ancient plant matter into coal.

• EXPERIENCE IN THE TREATMENT OF PATIENTS WITH RHEUMATISM IN INACTIVE PHASE USING LOW-TEMPERATURE DILUTED MUD BATHS, Balasheva, L/I/, Gadzhi, F.I., Vopr. Kurortol, Fizioter. Lech. Fiz. Kult., 36, 240-242, 1971
• HUMIC ACIDS IN THE THERAPEUTIC MUDS WITH A SPECIAL REFERENCE TO THEIR PHYSIOLOGICAL ACTIVITY, Amosova, Ya.M., Kosyanova, Z.F., Orlov, D.S., Tikhomirova, K.S., Shinkarenko, A.L, Kurortol. Fizioter. 27(4), 1-6, 1990
• Effects of Implanted bovine calcium hydroxyapatite with humate. Kreutz, Schlikekewey, W. Arch. Orthop. Trauma Surg., 1992, Vol. 111; Issue 5; pages 259-264
• SODIUM HUMATE IN THE TREATMENT OF OSTEOARTHROSIS PATIENTS, Iubitskaia, N.S., Ivanov, E.M., Vopr. Kurortol, Fizioter. Lech. Fiz. Kult., 1995 (5), 22-24
• CYTOKINE LEVELS IN OSTEOARTHROSIS PATIENTS UNDERGOING MUD BATH THERAPY, Bellometti, S., Giannini, S., Sartori, L., Crepaldi, G., Int. J. Clin. Pharmacol. Res. 17, 149-153, 1997
• MEDICAL ASPECTS AND APPLICATIONS OF HUMIC SUBSTANCES, R, Klocking, B. Helbig, Biopolymers for Medical and Pharmaceutical Applications, Edited by A. Steinbuchel and R.H. Marchessault, 2005 WILLEY-VCH Verlag GmbH & Co. KGaA, Weinheim, ISBN: 3-527-31154-8

• Bacteriostatic and bacteriocidal method using fulvic acid derivatives, United States Patent 5,204,368, Inventors: Cronje , et al., Patent Issued: April 20, 1993.
• Mode of action of anhydrofulvic acid against Candida utilis ATCC 42402 under acidic conditions, Fujita K, Nagamine Y, Ping X, and M. Taniguchi M. 1999, J Antibiot (Tokyo). 1999 Jul;52(7):628-34.
• Topical Management of Acne Vulgaris using Carbohydrate-derived Fulvic Acid (CHD-FA), A.J. Scott, J.R. Snyman, C.E.J. van Rensburg, M. Smit, Department of Pharmacology, Faculty of Health Sciences,University of Pretoria, For partial fulfilment of degree: Master of Science in Pharmacology.
• AN IN VITRO INVESTIGATION OF THE ANTIMICROBIAL ACTIVITY OF OXIFULVIC ACID, C.E.J. van Rensburg, A, van Straaten, J. Dekker, Journal of Antimicrobial Chemotherapy (2000), 46, 847-863.
• Topical application of oxifulvic acid suppresses the cutaneous immune response in mice, C.E.J. Van Rensburg, S.C.K. Malfeld, J.Dekker, Drug Development Research, Volume 53, Issue 1, May 2001, Pages 29–32.
• Compositions and methods of treatment using peat derivatives, United States Patent 6,267,962, Inventor: Hart , et al., Publication date: July 31, 2001.
• Pilot study to evaluate the safety and therapeutic efficacy of topical oxifulvic acid in atopic VOLUNTEERS, J.R. Snyman, J. Dekker, S.C.K. Malfeld, C.E.J. van Rensburg, Drug Development Research, September 2002.
• Fulvic acid and its use in the treatment of various conditions, United States Patent 6,569,900, Inventor: Dekker , et al., Publication date: May 27, 2003.
• Evaluation of the permeation of peat substances through human skin in vitro, Beer AM, Junginger HE, Lukanov J, and P. Sagorchev 2003, Int J Pharm. 2003 Mar 6;253(1-2):169-75.
• Evaluation of the permeation of peat substances through human skin in vitro, Beer AM, Junginger HE, Lukanov J, and P. Sagorchev 2003, Int J Pharm. 2003 Mar 6;253(1-2):169-75.
• MEDICAL ASPECTS AND APPLICATIONS OF HUMIC SUBSTANCES, R, Klocking, B. Helbig, Biopolymers for Medical and Pharmaceutical Applications, Edited by A. Steinbuchel and R.H. Marchessault, 2005 WILLEY-VCH Verlag GmbH & Co. KGaA, Weinheim, ISBN: 3-527-31154-8
• Fulvic acid and its use in the treatment of candida infections, Publication number: EP1700599, Publication date: 2006-09-13, Inventor: Dekker J. (ZA); Medlen C.E.(ZA).
• Fulvic acid and its use in the treatment of inflammation, European Publication number: EP1700600, Publication date: 2006-09-13, Inventor: Dekker J. (ZA); Medlen C.E.(ZA)
• RANDOMIZED, PARALLEL-GROUP, DOUBLE-BLIND, CONTROLLED STUDY TO EVALUATE THE EFFICACY AND SAFETY OF CARBOHYDRATE-DERIVED FULVIC ACID IN TOPICAL TREATMENT OF ECZEMA, J.J. Gandy, J.R. Snyman, C.E.J. van Rensburg, Clinical, cosmetic and Investigational Dermatology, Dove Press, 7 September 2011.
• Effect of fulvic acid on ultraviolet induced skin aging: The effect of fulvic acid on fibroblasts and matrix metalloproteinase, Kinoshita, H.a, Kinoshita, M.b, Takahashi, A.c, Yuasa, S.c, Fukuda, K.c, Nishinihon Journal of Dermatology, Volume 74, Issue 4, 2012, Pages 427-431.
• CARBOHYDRATE DERIVED FULVIC ACID: AN IN VITRO INVESTIGATION OF A NOVELMEMBRANE ACTIVE ANTISEPTIC AGENT AGAINST CANDIDA ALBICANS BIOFILMS, L. Sherry, A. Jose, C. Murray, C. Williamson, B. Jones, O. Millington, J. Bagg, G. Ramage, Frontiers in Microbiology, Antimicrobials, Resistance and Chemotherapy, 29 March 2012, Volume 3, Article 116.
• The Anti-inflammatory Properties of Humic Substances: A Mini Review, C.E.J. van Rensburg, Phytotherapy Research,  Volume 29, Issue 6, June 2015, Pages 791–795.